Information de reference pour ce titreAccession Number: | 01445483-201011000-00024.
|
Author: | Tomlinson, Claire L. PhD; Stowe, Rebecca PhD; Patel, Smitaa MSc; Rick, Caroline PhD; Gray, Richard MSc; Clarke, Carl E. MD
|
Institution: | (1)Birmingham Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom (2)Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham, United Kingdom (3)School of Clinical and Experimental Medicine, College of Medicine and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, United Kingdom
|
Title: | |
Source: | Movement Disorders. 25(15):2649-2653, November 15, 2010.
|
Author Keywords: | Parkinson's disease; treatment; levodopa; levodopa equivalent dose.
|
References: | 1. Fahn S,Shoulson I,Kieburtz K, et al. Levodopa and the progression of Parkinson's disease. N Engl J Med 2004; 351: 2498-2508.
2. Parkes JD,Baxter RC,Marsden CD,Rees JE. Comparative trial of benzhexol, amantadine, and levodopa in the treatment of Parkinson's disease. J Neurol Neurosurg Psychiatry 1974; 37: 422-426.
3. Baron MS,Vitek JL,Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996; 40: 355-366.
4. Baron MS,Vitek JL,Bakay RAE, et al. Treatment of advanced Parkinson's disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study. Mov Disord 2000; 15: 230-237.
5. Brodsky MA,Godbold J,Roth T,Olanow CW. Sleepiness in Parkinson's disease: a controlled study. Mov Disord 2003; 18: 668-672.
6. Cabrini S,Baratti M,Bonfa F,Cabri G,Uber E,Avanzi M. Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviors associated to dopamine replacement therapy in Parkinson's disease. Neurol Sci 2009; 30: 307-313.
7. Canesi M,Antonini A,Mariani CB, et al. An overnight switch to ropinirole therapy in patients with Parkinson's disease. J Neural Transm 1999; 106: 925-929.
8. Castro-Caldas A,Delwaide P,Jost W, et al. The Parkinson-control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease. Mov Disord 2006; 21: 500-509.
9. Coban A,Hanagasi HA,Karamursel S,Barlas O. Comparison of unilateral pallidotomy and subthalamotomy findings in advanced idiopathic Parkinson's disease. Br J Neurosurg 2009; 23: 23-29.
10. De Bie RMA,de Haan RJ,Nijssen PCG, et al. Unilateral pallidotomy in Parkinson's disease: a randomised, single-blind, multicentre trial. Lancet 1999; 354: 1665-1669.
11. Deuschl G,Schade-Brittinger C,Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006; 355: 896-908.
12. Dewey RB,Hutton JT,Lewitt PA,Factor SA. A randomized, double-blind, placebo-controlled trial of subcutaneously injected apomorphine for parkinsonian off-state events. Arch Neurol 2001; 58: 1385-1392.
13. Esselink RAJ,De Bie RMA,de Haan RJ, et al. Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in PD-a randomized trial. Neurology 2004; 62: 201-207.
14. Evans AH,Katzenschlager R,Paviour D, et al. Punding in Parkinson's disease: its relation to the dopamine dysregulation syndrome. Mov Disord 2004; 19: 397-405.
15. Fan WH,Ding H,Ma JH,Chan P. Impulse control disorders in Parkinson's disease in a Chinese population. Neurosci Lett 2009; 465: 6-9.
16. Fenelon G,Mahieux F,Huon R,Ziegler M. Hallucinations in Parkinson's disease-prevalence, phenomenology and risk factors. Brain 2000; 123: 733-745.
17. Fine J,Duff J,Chen R,Hutchison W,Lozano AM,Lang AE. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease. N Engl J Med 2000; 342: 1708-1714.
18. Ghorayeb I,Loundou A,Auquier P,Dauvilliers Y,Bioulac B,Tison F. A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France. Mov Disord 2007; 22: 1567-1572.
19. Giladi N,Boroojerdi B,Korczyn AD,Burn DJ,Clarke CE,Schapira AH. Rotigotine transdermal patch in early Parkinson's disease: a randomized, double-blind, controlled study versus placebo and ropinirole. Mov Disord 2007; 22: 2398-2404.
20. Goetz CG,Blasucci L,Stebbins GT. Switching dopamine agonists in advanced Parkinson's disease-is rapid titration preferable to slow? Neurology 1999; 52: 1227-1229.
21. Grosset K,Needleman F,Macphee G,Grosset D. Switching from ergot to nonergot dopamine agonists in Parkinson's disease: a clinical series and five-drug dose conversion table. Mov Disord 2004; 19: 1370-1374.
22. Gupta M,Singh G,Khwaja GA,Mehndiratta MM. Hallucinations in Parkinson's disease-a study of forty three patients. JAssoc Physicians India 2004; 52: 703-706.
23. Hagell P,Piccini P,Bjorklund A, et al. Dyskinesias following neural transplantation in Parkinson's disease. Nat Neurosci 2002; 5: 627-628.
24. Hobson DE,Lang AE,Martin WRW,Razmy A,Rivest J,Fleming J. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease-a survey by the Canadian Movement Disorders Group. JAMA 2002; 287: 455-463.
25. Imamura A,Geda YE,Slowinski J,Wszolek ZK,Brown LA,Uitti RJ. Medications used to treat Parkinson's disease and the risk of gambling. Eur J Neurol 2008; 15: 350-354.
26. Junghanns S,Glockler T,Reichmann H. Switching and combining of dopamine agonists. J Neurol 2004; 251: 19-23.
27. Katzenschlager R,Head J,Schrag A,Ben-Shlomo Y,Evans A,Lees AJ. Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD. Neurology 2008; 71: 474-480.
28. Kiziltan G,Ozekmekci S,Ertan S,Ertan T,Erginoz E. Relationship between age and subtypes of psychotic symptoms in Parkinson's disease. J Neurol 2007; 254: 448-452.
29. Koller W,Stacy M. Other formulations and future considerations for apomorphine for subcutaneous injection therapy. Neurology 2004; 62: S22-S26.
30. Konczak J,Krawczewski K,Tuite P,Maschke M. The perception of passive motion in Parkinson's disease. J Neurol 2007; 254: 655-663.
31. Krack P,Pollak P,Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998; 121: 451-457.
32. Krause M,Fogel W,Heck A, et al. Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internus. J Neurol Neurosurg Psychiatry 2001; 70: 464-470.
33. Lang AE,Lozano AM,Montgomery E,Duff J,Tasker R,Hutchinson W. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997; 337: 1036-1042.
34. Lee JY,Jeon BS,Paek SH,Lim YH,Kim MR,Kim C. Reprogramming guided by the fused images of MRI and CT in subthalamic nucleus stimulation in Parkinson disease. Clin Neurol Neurosurg 2010; 112: 47-53.
35. Lozano AM,Lang AE,Galvezjimenez N, et al. Effect of gpi pallidotomy on motor function in Parkinson's disease. Lancet 1995; 346: 1383-1387.
36. Matsui H,Nishinaka K,Oda M,Komatsu K,Kubori T,Udaka F. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms? Parkinsonism Relat Dis 2006; 12: 284-288.
37. Minguez-Castellanos A,Escamilla-Sevilla F,Katati MJ, et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry 2005; 76: 34-39.
38. Moller JC,Korner Y,Dodel R, et al. Pharmacotherapy of Parkinson's disease in Germany. J Neurol 2005; 252: 926-935.
39. Moro E,Scerrati M,Romito LMA,Roselli R,Tonali P,Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999; 53: 85-90.
40. Mutez E,Duhamel A,Defebvre L,Bordet R,Destee A,Kreisler A. Lipid-lowering drugs are associated with delayed onset and slower course of Parkinson's disease. Pharmacol Res 2009; 60: 41-45.
41. Nowak DA,Ameli M,Kemper F, et al. Arbitrary visuomotor mapping during object manipulation in Parkinson's disease. Mov Disord 2009; 24: 1925-1933.
42. Olanow CW,Koller W,Goetz CG, et al. Autologous transplantation of adrenal-medulla in Parkinson's disease-18-month results. Arch Neurol 1990; 47: 1286-1289.
43. Ondo WG,Silay Y,Almaguer M,Jankovic J. Subthalamic deep brain stimulation in patients with a previous pallidotomy. Mov Disord 2006; 21: 1252-1254.
44. Ostergaard K,Sunde N,Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002; 17: 693-700.
45. Pahwa R,Wilkinson SB,Overman J,Lyons KE. Bilateral subthalamic stimulation in patients with Parkinson disease: long-term follow up. J Neurosurg 2003; 99: 71-77.
46. Parkin SG,Gregory RP,Scott R, et al. Unilateral and bilateral pallidotomy for idiopathic Parkinson's disease: a case series of 115 patients. Mov Disord 2002; 17: 682-692.
47. Peralta CM,Frauscher B,Seppi K, et al. Restless legs syndrome in Parkinson's disease. Mov Disord 2009; 24: 2076-2080.
48. Reimer J,Grabowski M,Lindvall O,Hagell P. Use and interpretation of on/off diaries in Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 396-400.
49. Romito LMA,Scerrati M,Contarino MF,Iacoangeli M,Bentivoglio AR,Albanese A. Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up. J Neurosurg Sci 2003; 47: 119-128.
50. The Deep-Brain Stimulation for Parkinson's Disease Study Group . Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001; 345: 956-963.
51. Thobois S,Mertens P,Guenot M, et al. Subthalamic nucleus stimulation in Parkinson's disease-clinical evaluation of 18 patients. J Neurol 2002; 249: 529-534.
52. Tir M,Devos D,Blond S, et al. Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients. Neurosurgery 2007; 61: 297-304.
53. Tseng HM,Su PC,Liu HM,Liou HH,Yen RF. Bilateral subthalamotomy for advanced Parkinson disease. Surg Neurol 2007; 68: S43-S51.
54. Vingerhoets FJG,Villemure JG,Temperli P,Pollo C,Pralong E,Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease-two-year follow-up. Neurology 2002; 58: 396-401.
55. Vitek JL,Bakay RAE,Freeman A, et al. Randomized trial of pallidotomy versus medical therapy for Parkinson's disease. Ann Neurol 2003; 53: 558-569.
56. Weaver FM,Follett K,Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009; 301: 63-73.
57. Wenzelburger R,Zhang BR,Pohle S, et al. Force overflow and levodopa-induced dyskinesias in Parkinson's disease. Brain 2002; 125: 871-879.
58. Williams-Gray CH,Foltynie T,Brayne CEG,Robbins TW,Barker RA. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007; 130: 1787-1798.
59. Stowe R. Ives N, Clarke CE, et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson's disease patients with motor complications. Cochrane Database Syst Rev. 2010, Issue 7.
|
Language: | English.
|
Document Type: | Brief Reports.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0885-3185
|
DOI Number: | https://dx.doi.org/10.1002/mds.2...- ouverture dans une nouvelle fenêtre
|
Annotation(s) | |
|
|